COMPARISON OF DISSOLUTION PROFILES: …
Docencia 507 COMPARISON OF DISSOLUTION PROFILES: CURRENT GUIDELINES A.Prior, P.Frutos, C.P.Correa Dpto. Farmacia y Tecnología Farmacéutica, Facultad de …
Download COMPARISON OF DISSOLUTION PROFILES: …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ESTIMACIÓN DE LA SOLUBILIDAD DE LA CAFEÍNA …
www.sefig.comTecnología Farmacéutica 117 ESTIMACIÓN DE LA SOLUBILIDAD DE LA CAFEÍNA MEDIANTE DISEÑOS DE MEZCLAS G. Hurtado Guevara a, M.D. Mingorance b y M.D. Contreras c a Universidad de Antioquia, Medellín, Colombia
Related documents
GUIDELINES FOR BIOAVAILABILITY & …
www.cdsco.nic.inGUIDELINES FOR BIOAVAILABILITY & BIOEQUIVALENCE STUDIES Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare,
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp1 English translation of Attachment 1 of Division-Notification 0229 No. 10 of the Pharmaceutical and Food Safety Bureau, dated February 29, 2012 Guideline for Bioequivalence Studies of Generic Products
Annex 9 - WHO
www.who.int441 Bioequivalence studies should be performed in compliance with the general regulatory requirements and recommendations on good practices as speci-
PROPOSAL TO WAIVE IN VIVO BIOEQUIVALENCE …
www.who.intWorking document QAS/04.109/Rev.1 page 4 local usage of the API, as to whether generic formulations should be subjected to in vivo bioequivalence (BE) studies or whether a Biowaiver can be applied.
Global Development Strategy for Generic Medicinal …
dgra.deGlobal Development Strategy for Generic Medicinal Products with Regard to Bioequivalence Studies – Special Focus on the Biowaiver Approach in Canada, Australia and Brazil